Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-26 @ 1:19 PM
NCT ID:
NCT06152406
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 or above
* Symptomatic AF, New York Heart Association (NYHA) class II-IV
* Willing to consent for the study
* AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following:
1. Impaired LV function, EF \<50 %. And or
2. Raised N-Terminal Pro B-type Natriuretic Peptide ( NT-ProBNP) \>365 ng/L
Exclusion Criteria:
* Patient who has already got a pacemaker in situ
* Known severe LVSD when biventricular device is the thought to be the preferred pacing modality
* Females in child bearing period
* Lack of capacity to consent
* Other serious medical condition with life expectancy of less than 1 year
* Less than 18 years
* Unwilling to consent for the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT06152406
Study Brief:
Protocol Section:
NCT06152406